COVID-19 : encore une place pour le tocilizumab ?
Domains
Human health and pathology| Origin | Files produced by the author(s) |
|---|
Journal Articles
La Revue de Médecine Interne
Year : 2021
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03707361
Submitted on : Wednesday, March 22, 2023-6:50:20 PM
Last modification on : Thursday, November 7, 2024-2:21:53 PM
Long-term archiving on : Friday, June 23, 2023-9:29:18 PM
Dates and versions
Licence
Identifiers
- HAL Id : hal-03707361 , version 1
- DOI : 10.1016/j.revmed.2020.11.016
- PII : S0248-8663(20)30829-8
- PUBMEDCENTRAL : PMC7691818
Cite
Q. Richier, L. Plaçais, K. Lacombe, O. Hermine. COVID-19 : encore une place pour le tocilizumab ?. La Revue de Médecine Interne, 2021, 42 (2), pp.73--78. ⟨10.1016/j.revmed.2020.11.016⟩. ⟨hal-03707361⟩
Collections
16
View
17
Download